Epigenetic changes have also been identified in human adipose-derived stem cells from infants with intrauterine growth retardation (IUGR) resulting in a down-regulation of CYCLIN-T2 expression, a gene controlling adipose maturation that confers risk of abnormal lipid metabolism (182). Here, CCNT2 is linked to fetal growth restriction.